| Dr Emil S Abdulhayoglu, MD | |
|
514 Eichenfeld Dr, Brandon, FL 33511-5955 | |
| (813) 571-7088 | |
| Not Available |
| Full Name | Dr Emil S Abdulhayoglu |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 514 Eichenfeld Dr, Brandon, Florida |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801860671 | NPI | - | NPPES |
| 223172 | Medicaid | SC | |
| 119945200 | Medicaid | FL | |
| 194305201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | M7806 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Preferred Vascular Services Northwest Llc | 1850552142 | 11 |
| Preferred Vascular Services Southeast Llc | 3577812312 | 12 |
| Preferred Vascular Services Northeast | 3577815695 | 6 |
| Preferred Vascular Services Cleveland Llc | 5991046369 | 5 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Entity Name | Preferred Vascular Services Northwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598037822 PECOS PAC ID: 1850552142 Enrollment ID: O20120413000013 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Entity Name | Preferred Vascular Services Southeast Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861992976 PECOS PAC ID: 3577812312 Enrollment ID: O20180828000280 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Entity Name | Preferred Vascular Services Southwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790285229 PECOS PAC ID: 0446502918 Enrollment ID: O20181010003246 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Entity Name | Preferred Vascular Services Macon Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437659455 PECOS PAC ID: 6406108984 Enrollment ID: O20181010003906 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Entity Name | Preferred Vascular Services Northeast |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780184218 PECOS PAC ID: 3577815695 Enrollment ID: O20181017002434 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emil S Abdulhayoglu, MD 9310 Persimmon Brook Trl Apt 102, Thonotosassa, FL 33592-3967 Ph: (281) 796-4300 | Dr Emil S Abdulhayoglu, MD 514 Eichenfeld Dr, Brandon, FL 33511-5955 Ph: (813) 571-7088 |
News Archive
In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.
A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products.
A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.
› Verified 2 days ago
Dr. Joanna G Ramirez, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 214 Morrison Rd, Ste 110, Brandon, FL 33511 Phone: 813-844-4300 Fax: 813-844-1909 | |
Syed Mustafa Zaidi, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 119 Oakfield Dr, Brandon, FL 33511 Phone: 407-788-1906 | |
Harshinder Singh, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 1159 Nikki View Dr, Brandon, FL 33511 Phone: 813-996-7272 Fax: 813-634-4306 | |
Jonathan P Axel, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 631 W Lumsden Rd, Brandon, FL 33511 Phone: 813-413-9119 Fax: 813-413-9122 | |
Dr. Monther Hafez Al-halawani, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 502 Corner Dr, Brandon, FL 33511 Phone: 813-643-4722 Fax: 813-651-3280 | |
Dr. Elizabeth J Carpenter, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 311 Noland Dr, Brandon, FL 33511 Phone: 813-333-1601 | |
Michael L Davis, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1218 Millennium Pkwy, Brandon, FL 33511 Phone: 813-684-5255 Fax: 813-654-7457 |